IRIS to supply MedAssets with automated urinalysis systems:
This article was originally published in Clinica
IRIS International, the Chatsworth, California-based manufacturer of automated IVD urinalysis systems, has won a three-year supply contract with MedAssets Supply Chain Systems. The agreement will enable the Atlanta, Georgia-based group purchasing organisation to help its subscribers meet the ongoing labour shortage in clinical labs, by offering them IRIS' full line of products, including its iQ200 and iQ200 Sprint automated urine chemistry analysers and systems. The agreement includes an option for automatic renewal for an additional 12 months.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.